“ Valsartan , a selective Ang II type 1 (AT1) receptor blocker, and N-acetylcysteine , an antioxidant, inhibited both of these modifications, indicating the contribution of AT1 receptor and reactive oxygen species to oxidation of Prx2 and phosphorylation of GRP58 by Ang II.”